Table 1.
Patient demographics and clinical characteristics with 15 different patients and 69 distinct bolus infusions of HTS
Characteristics | N (%) or median (interquartile range) |
---|---|
n (patients) | 15 |
Age | 35 (23–54) |
Sex (male) | 11 (73.3%) |
Best GCS | 7 (6–8) |
Best GCS-motor | 5 (4–5) |
Pupillary light reflex | |
Bilateral reactive | 9 (60%) |
Unilateral unreactive | 4 (26.6%) |
Bilateral unreactive | 2 (13.3%) |
Pre-hospital hypoxia | 10 (66.6%) |
Pre-hospital hypotension | 2 (13.3%) |
CT-epidural hematoma | 2 (13.3%) |
Mean ISS | 25 (25–27) |
AIS-head/brain | 5 (4.5–5) |
Marshall classification category of 1st head-CT | |
III | 4 (26.6%) |
IV | 6 (40%) |
V | 5 (33.3%) |
Median GOSE outcome 1 month | 4 (1–5) |
Treatment was a 140-ml 7.5% hypertonic saline solution
AIS, abbreviated injury scale; CT, computed tomography; HTS, hypertonic saline; ISS, injury severity score; GCS, Glasgow coma score; GOSE, Glasgow Outcome Scale-Extended